177 related articles for article (PubMed ID: 9740137)
1. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: the clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban.
Laposata M; Green D; Van Cott EM; Barrowcliffe TW; Goodnight SH; Sosolik RC
Arch Pathol Lab Med; 1998 Sep; 122(9):799-807. PubMed ID: 9740137
[TBL] [Abstract][Full Text] [Related]
2. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
Fairweather RB; Ansell J; van den Besselaar AM; Brandt JT; Bussey HI; Poller L; Triplett DA; White RH
Arch Pathol Lab Med; 1998 Sep; 122(9):768-81. PubMed ID: 9740135
[TBL] [Abstract][Full Text] [Related]
3. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy.
Olson JD; Arkin CF; Brandt JT; Cunningham MT; Giles A; Koepke JA; Witte DL
Arch Pathol Lab Med; 1998 Sep; 122(9):782-98. PubMed ID: 9740136
[TBL] [Abstract][Full Text] [Related]
4. New treatment options for heparin-induced thrombocytopenia.
Ortel TL; Chong BH
Semin Hematol; 1998 Oct; 35(4 Suppl 5):26-34; discussion 35-6. PubMed ID: 9855181
[TBL] [Abstract][Full Text] [Related]
5. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Hirsh J; Bauer KA; Donati MB; Gould M; Samama MM; Weitz JI
Chest; 2008 Jun; 133(6 Suppl):141S-159S. PubMed ID: 18574264
[TBL] [Abstract][Full Text] [Related]
6. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
[No Abstract] [Full Text] [Related]
7. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
Gurbuz AT; Elliott WG; Zia AA
Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
[TBL] [Abstract][Full Text] [Related]
8. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Garcia DA; Baglin TP; Weitz JI; Samama MM
Chest; 2012 Feb; 141(2 Suppl):e24S-e43S. PubMed ID: 22315264
[TBL] [Abstract][Full Text] [Related]
9. Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
Matthai WH
Expert Opin Pharmacother; 2006 Feb; 7(3):267-76. PubMed ID: 16448321
[TBL] [Abstract][Full Text] [Related]
10. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass.
von Segesser LK; Mueller X; Marty B; Horisberger J; Corno A
Perfusion; 2001 Sep; 16(5):411-6. PubMed ID: 11565896
[TBL] [Abstract][Full Text] [Related]
11. [Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
Steinfeldt T; Rolfes C
Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):304-10; quiz 312. PubMed ID: 18409125
[TBL] [Abstract][Full Text] [Related]
12. [Anticoagulants in clinical practice].
Boneu B
Rev Prat; 1999 Oct; 49(15):1641-7. PubMed ID: 10581994
[TBL] [Abstract][Full Text] [Related]
13. Treatment of heparin-induced thrombocytopenia.
Dager WE; White RH
Ann Pharmacother; 2002 Mar; 36(3):489-503. PubMed ID: 11895064
[TBL] [Abstract][Full Text] [Related]
14. Ardeparin and danaparoid.
Dimens Crit Care Nurs; 2000; 19(4):13-4. PubMed ID: 11998151
[No Abstract] [Full Text] [Related]
15. [Use of low molecular weight heparins by dermatologists].
Maakaroun A; Gruel Y
Ann Dermatol Venereol; 2003 Apr; 130(4):473-8. PubMed ID: 12843865
[No Abstract] [Full Text] [Related]
16. Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
Bartholomew JR
Chest; 2005 Feb; 127(2 Suppl):27S-34S. PubMed ID: 15706028
[TBL] [Abstract][Full Text] [Related]
17. Danaparoid in the prevention of thromboembolic complications.
Skoutakis VA
Ann Pharmacother; 1997; 31(7-8):876-87. PubMed ID: 9220051
[TBL] [Abstract][Full Text] [Related]
18. Current considerations in the use of the APTT in monitoring unfractionated heparin.
Nelson DE
Clin Lab Sci; 1999; 12(6):359-64. PubMed ID: 10724634
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation in continuous renal replacement therapy.
Vargas Hein O; Kox WJ; Spies C
Contrib Nephrol; 2004; 144():308-16. PubMed ID: 15264419
[No Abstract] [Full Text] [Related]
20. Heparin-induced thrombocytopenia in France, 1980-1998.
Nguyen P; de Maistre E; Cornillet-Lefebvre P; Regnault V; Lecompte T
Semin Thromb Hemost; 1999; 25 Suppl 1():9-15. PubMed ID: 10357146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
